Search Within

Paul Marks

Formats
  1. Journal Article (121)
  2. Meeting Abstract (47)
  3. Book Section (10)
  4. Book Whole (4)
  5. Conference Paper (4)
Groups
  1. Department of Medicine (18)
  2. Center for Hematologic Malignancies (15)
  3. Solid Tumor Oncology Division (14)
  4. Surgery (13)
  5. GSK Faculty (12)
  6. Genitourinary Oncology Service (12)

More Groups

People
  1. Richard Rifkind (113)
  2. Victoria Richon (77)
  3. Lang Ngo (27)
  4. Gisela Venta-Perez (20)
  5. William Kelly (16)
  6. Weisheng Xu (13)

More People

Years
  1. 2015 (2)
  2. 2014 (2)
  3. 2013 (3)
  4. 2012 (4)
  5. 2011 (3)
  6. 2010 (6)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (35)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (19)
  3. Cancer Research (15)
  4. Blood (9)
  5. Clinical Cancer Research (9)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (48)
  2. National Academy of Sciences (35)
  3. American Society of Hematology (9)
  4. Nature Publishing Group (8)
  5. Elsevier Inc. (7)
  6. John Wiley & Sons (6)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ribosomal protein S3 as a target for differentiation-inducing hybrid polar compounds
    Meeting Abstract

    Zhou, X.; Richon, V. M.; Ngo, L.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors
    Meeting Abstract

    Richon, V. M.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors induce remission in a transgenic model of therapy resistant acute promyelocytic leukemia
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrel, R. P. Jr; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
    Journal Article

    Coffey, D. C.; Kutko, M. C.; Glick, R. D.; Swendeman, S. L.; Butler, L.; Rifkind, R.; Marks, P. A.; Richon, V. M.; LaQuaglia, M. P.
    Medical and Pediatric Oncology (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
    Journal Article

    Marks, P. A.; Richon, V. M.; Rifkind, R. A.
    JNCI: Journal of the National Cancer Institute (2000)

    Fulltext@MSK | Save
  • Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras
    Journal Article

    Zhou, X.; Richon, V. M.; Wang, A. H.; Yang, X. J.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitor selectively induces p21WAF1 expressjon and gene-associated histone acetylation
    Journal Article

    Richon, V. M.; Sandhoff, T. W.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5
    Journal Article

    Zhou, X.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Journal Article

    Butler, L. M.; Agus, D. B.; Scher, H. I.; Higgins, B.; Rose, A.; Cordon-Cardo, C.; Thaler, H. T.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.
    Cancer Research (2000)

    Fulltext@MSK | Save
  • Induction of apoptosis in human neuroblastoma by a histone deacetylase inhibitor
    Meeting Abstract

    Glick, R. D.; Swendeman, S.; Coffey, D. C.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; La Quaglia, M. P.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save